tiprankstipranks
Clal Biotechnology Industries Ltd (IL:CBI)
TASE:CBI
Israel Market
CBI
Clal Biotech
RESEARCH TOOLSreports

Clal Biotech (CBI) Income Statement

0 Followers

Clal Biotech Income Statement

Last quarter (Q2 2025), Clal Biotech's total revenue was ₪0.00, a decrease of ― from the same quarter last year. In Q2, Clal Biotech's net income was ₪-5.17M. See Clal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₪ 835.00K₪ 433.00K₪ 104.00K₪ 370.00K₪ 224.00K
Gross Profit
₪ 364.00K₪ -183.00K₪ 104.00K₪ 370.00K₪ 224.00K
Operating Expenses
₪ 18.78M₪ 6.34M₪ 10.29M₪ 12.27M₪ 77.47M
Depreciation and Amortization
₪ 216.00K₪ 283.00K₪ 526.00K₪ 17.64M₪ 22.51M
EBITDA
₪ -19.83M₪ -6.34M₪ -24.02M₪ 64.22M₪ -55.08M
Operating Income
₪ -18.41M₪ -6.34M₪ -10.18M₪ -27.42M₪ -77.59M
Other Income/Expenses
₪ -1.76M₪ -68.73M₪ -17.91M₪ -13.61M₪ 11.00M
Pretax Income
₪ -20.17M₪ -75.07M₪ -28.09M₪ -41.02M₪ -66.59M
Net Income
₪ -13.32M₪ -62.46M₪ -31.05M₪ -61.74M₪ -89.58M
Per Share Metrics
Basic EPS
₪ -0.08₪ -0.40₪ -0.20₪ -0.39₪ -0.57
Diluted EPS
₪ -0.08₪ -0.40₪ -0.20₪ -0.39₪ -0.57
Weighted Average Shares Outstanding
 156.85M 158.44M 156.85M 156.85M 158.44M
Weighted Average Shares Outstanding (Diluted)
 156.85M 158.44M 156.85M 156.85M 158.44M
Currency in ILS

Clal Biotech Earnings and Revenue History